Medable Inc.

PALO ALTO, CA · Founded 2012 · Digital health · Private

Agentic AI platform for clinical trial management with electronic clinical outcome assessment (eCOA) software

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · medable.com

Sector: Digital health
Headquarters: PALO ALTO, CA
Founded: 2012
Latest Form D: $304M, Nov 2021
Total capital: $501M

Federal grants: None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised: $501M; 7 Form D · last Nov 2021; 60 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 5; 7 pending · first 2022; Rank in peer group#15 of 312

Capital timeline

Latest events

Nov 2021Private capital raisedForm D · SEC · 7th filing$304M
Apr 2021Private capital raisedForm D · SEC · 6th filing$78M
Nov 2020Private capital raisedForm D · SEC · 5th filing$63.6M
Oct 2020Private capital raisedForm D · SEC · 4th filing$10M
Apr 2020Private capital raisedForm D · SEC · 3rd filing$25.7M
Apr 2020Private capital raisedForm D · SEC · 2nd filing$16.1M
Dec 2015Private capital raisedForm D · SEC · 1st filing$3.2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 312 peers

Line = median

Digital health · Platform

Granted patents#15 · top 5%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Michelle LongmireResearcherExecutive Officer, DirectorLinked by 2 patents
Anna A. LongDirectorNamed in SEC Form D filings
David A. HartwigDirectorNamed in SEC Form D filings
Mahkam ZanganehDirectorNamed in SEC Form D filings
Perry A. RobinsonExecutive OfficerNamed in SEC Form D filings
Richard A. LimDirectorNamed in SEC Form D filings

Show all 9 people

Robert DugganDirectorNamed in SEC Form D filings
Timothy R. SmithExecutive Officer, DirectorNamed in SEC Form D filings
Young A. SohnDirectorNamed in SEC Form D filings

What it has protected

USPTO · 5 granted of 12

Feb 13, 2024GrantedMethods, Systems, And Media For Determining Application Compliance With The Health Insurance Portability And Accountability ActUSPTOUS 11,901,050
Jun 6, 2023GrantedMethod And System Enabling Digital Biomarker Data Integration And Analysis For Clinical Treatment ImpactUSPTOUS 11,670,421
Apr 18, 2023GrantedMethods and Systems for Creating and Managing a Research Study and Deploying via Mobile and Web Utilizing a Research ModuleUSPTOUS 11,631,041

Show all 12 patent records

Methods, Systems, And Media For Determining Application Compliance With The Health Insurance Portability And Accountability ActFeb 13, 2024 · US 11,901,050Granted
Method And System Enabling Digital Biomarker Data Integration And Analysis For Clinical Treatment ImpactJun 6, 2023 · US 11,670,421Granted
Methods and Systems for Creating and Managing a Research Study and Deploying via Mobile and Web Utilizing a Research ModuleApr 18, 2023 · US 11,631,041Granted
Method And System To Integrate Data, Analyze And Develop Improved Care Plan For A Patient At HomeFeb 21, 2023 · US 11,587,682Granted
Methods And Systems For Health Insurance Portability And Accountability Act Application ComplianceSep 20, 2022 · US 11,450,415Granted
Methods And Systems For Creating And Managing A Research Study And Deploying Via Mobile And Web Utilizing A Research ModuleApplication PCTUS2017034335Pending
Methods And Systems For Creating And Managing A Research Study And Deploying Via Mobile And Web Utilizing A Research ModuleApplication 62341062Pending
Methods and Systems for Health Insurance Portability and Accountability Act Application ComplianceApplication 62149486Pending
Method And System To Integrate Data, Analyze And Develop Improved Care Plan For A Patient At HomeApplication PCTUS2021041325Pending
Method And Systemenbling Digital Biomarker Data Integration And Analysis For Clinical Treatment ImpactApplication PCTUS2021025259Pending
Method And System Enabling Digital Biomarker Data Integration And Analysis For Clinical Treatment ImpactApplication 63033119Pending
Method And System To Develop Improved Care Plans For Patients And Their Informal Caregivers At HomeApplication 63025397Pending

BioSignal Analytics, IncSimilar federal contract value in Digital health · null in contracts
Oncospace, Inc.Similar federal contract value in Digital health · null in contracts
RADIAL ANALYTICS, INC.Similar federal contract value in Digital health · null in contracts
VMT, INC.Similar federal contract value in Digital health · null in contracts
HERA GLOBAL TECH INC.Similar federal contract value in Digital health · null in contracts
LIFESPAN DIGITAL HEALTH, LLCSimilar federal contract value in Digital health · null in contracts

Regulatory activity · Digital health

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.